Pongwecharak Juraporn, Treeranurat Tarakamon
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112, Thailand.
Pharm World Sci. 2010 Jun;32(3):329-33. doi: 10.1007/s11096-010-9373-1. Epub 2010 Feb 26.
To identify subjects with pre-hypertension and elevated cardiovascular risk factors in a community pharmacy and to assess their readiness to adopt lifestyle changes.
An accredited community pharmacy in Songkla province, Thailand.
Subjects aged >or= 35 years old and reporting no hypertension or other cardiovascular disease were included. Blood pressure was measured using the Microlife BP 3AC1-1. Those with pre-hypertension or hypertension defined by the JNC 7, and reporting no diabetes and/or dyslipidemia, were checked for blood glucose and/or total cholesterol with the Accutrend GCT monitor. Other risk factors were collected. Their readiness to adopt healthy lifestyles was evaluated.
The prevalence of pre-hypertension and elevated cardiovascular risk factors.
350 subjects met the study criteria. Approximately 36 and 29% were pre-hypertensive and hypertensive, respectively. Two of these had blood glucose > 200 mg/dl but about 47% had total cholesterol > 200 mg/dl. Most common modifiable cardiovascular risks were inadequate exercise and elevated body mass index (approximately 52% each). Almost 40% were ready to adopt healthy lifestyles within 1-6 months.
Subjects at risk for hypertension and cardiovascular disease can be identified by community pharmacists, with the use of point-of-care devices and careful interview.
在社区药房中识别患有高血压前期和心血管危险因素升高的受试者，并评估他们采取生活方式改变的意愿。
泰国宋卡府一家经认可的社区药房。
纳入年龄≥35岁且报告无高血压或其他心血管疾病的受试者。使用Microlife BP 3AC1-1测量血压。对于那些根据美国国家高血压教育计划（JNC 7）定义为高血压前期或高血压且报告无糖尿病和/或血脂异常的受试者，使用Accutrend GCT监测仪检查血糖和/或总胆固醇。收集其他危险因素。评估他们采取健康生活方式的意愿。
高血压前期和心血管危险因素升高的患病率。
350名受试者符合研究标准。分别约有36%和29%为高血压前期和高血压患者。其中两人血糖>200mg/dl，但约47%的人总胆固醇>200mg/dl。最常见的可改变心血管危险因素是运动不足和体重指数升高（各约52%）。近40%的人准备在1 - 6个月内采取健康生活方式。
社区药剂师可通过使用即时检测设备并仔细询问来识别有高血压和心血管疾病风险的受试者。
